# Agilent Technologies (A) financials

Agilent Technologies reported revenue of $6.95 billion for fiscal year 2025 (the twelve months to 31 Oct 2025), up 6.7% from fiscal 2024. Net income was $1.30 billion and diluted earnings per share $4.57.

In its latest reported quarter, the third quarter of fiscal 2026 (the three months to 31 Jul 2026), revenue was $1.88 billion, up 8.1% from a year earlier.

Source: Agilent Technologies's annual and quarterly reports, compiled and checked by AapWire. Latest report filed 1 Sep 2026. Amounts in USD. Page: https://aapwire.com/stocks/A. Retrieved 2026-11-16.

## Latest results: Q3 FY2026

Agilent Technologies reported revenue of $1.88 billion, up 8.1% from a year earlier, net income of $362 million and diluted earnings per share of $1.28 against $1.18 for the third quarter of fiscal 2026 (the three months to 31 Jul 2026).

From its quarterly report, the results first announced on 26 Aug 2026.

| Measure | Q3 FY2026 | Q3 FY2025 | Change |
| --- | ---: | ---: | ---: |
| Revenue | $1.88B | $1.74B | +8.1% |
| Gross profit | $1.04B | $888.0M | +17.3% |
| Gross margin | 55.5% | 51.1% | +4.4 pts |
| Operating income | $444.0M | $360.0M | +23.3% |
| Operating margin | 23.6% | 20.7% | +2.9 pts |
| Net income | $362.0M | $336.0M | +7.7% |
| Diluted EPS | $1.28 | $1.18 | +8.5% |
| Operating cash flow | $519.0M | $362.0M | +43.4% |
| Capital expenditure | $80.00M | $103.0M | −22.3% |
| Free cash flow | $439.0M | $259.0M | +69.5% |

Page: https://aapwire.com/stocks/A/earnings

## Annual figures (fiscal years)

| Measure | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $4.20B | $4.47B | $4.91B | $5.16B | $5.34B | $6.32B | $6.85B | $6.83B | $6.51B | $6.95B |
| Revenue growth | +4.1% | +6.4% | +9.9% | +5.1% | +3.4% | +18.4% | +8.4% | −0.2% | −4.7% | +6.7% |
| Gross profit | $2.20B | $2.41B | $2.68B | $2.81B | $2.84B | $3.41B | $3.72B | $3.46B | $3.54B | $3.64B |
| Operating income | $615.0M | $807.0M | $904.0M | $941.0M | $846.0M | $1.35B | $1.62B | $1.35B | $1.49B | $1.48B |
| Net income | $462.0M | $684.0M | $316.0M | $1.07B | $719.0M | $1.21B | $1.25B | $1.24B | $1.29B | $1.30B |
| Diluted EPS | $1.40 | $2.10 | $0.97 | $3.37 | $2.30 | $3.94 | $4.18 | $4.19 | $4.43 | $4.57 |
| Operating cash flow | $793.0M | $889.0M | $1.09B | $1.02B | $921.0M | $1.49B | $1.31B | $1.77B | $1.75B | $1.56B |
| Capital expenditure | $139.0M | $176.0M | $177.0M | $155.0M | $119.0M | $188.0M | $291.0M | $298.0M | $378.0M | $407.0M |
| Free cash flow | $654.0M | $713.0M | $910.0M | $866.0M | $802.0M | $1.30B | $1.02B | $1.47B | $1.37B | $1.15B |
| Gross margin | 52.3% | 53.9% | 54.5% | 54.3% | 53.1% | 53.9% | 54.4% | 50.7% | 54.3% | 52.4% |
| Operating margin | 14.6% | 18.0% | 18.4% | 18.2% | 15.8% | 21.3% | 23.6% | 19.8% | 22.9% | 21.3% |
| Net margin | 11.0% | 15.3% | 6.4% | 20.7% | 13.5% | 19.1% | 18.3% | 18.1% | 19.8% | 18.8% |
| Cash and equivalents | $2.29B | $2.68B | $2.25B | $1.38B | $1.44B | $1.48B | $1.05B | $1.59B | $1.33B | $1.79B |
| Total debt | $1.89B | $2.00B | $1.79B | $2.40B | $2.54B | $2.91B | $2.92B | $2.90B | $3.57B | $3.54B |
| Shareholders' equity | $4.24B | $4.83B | $4.57B | $4.75B | $4.87B | $5.39B | $5.30B | $5.84B | $5.90B | $6.74B |
| Diluted shares | 329M | 326M | 325M | 318M | 312M | 307M | 300M | 296M | 291M | 285M |
| Dividends per share | $0.46 | $0.53 | $0.60 | $0.66 | $0.72 | $0.78 | $0.84 | $0.90 | $0.94 | $0.99 |

## Quarterly figures (last eight fiscal quarters)

| Measure | Q4 FY2024 | Q1 FY2025 | Q2 FY2025 | Q3 FY2025 | Q4 FY2025 | Q1 FY2026 | Q2 FY2026 | Q3 FY2026 |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $1.70B | $1.68B | $1.67B | $1.74B | $1.86B | $1.80B | $1.83B | $1.88B |
| Revenue, year on year | +0.8% | +1.4% | +6.0% | +10.1% | +9.4% | +7.0% | +10.0% | +8.1% |
| Gross margin | 53.9% | 53.5% | 51.9% | 51.1% | 53.2% | 52.6% | 54.0% | 55.5% |
| Operating income | $408.0M | $376.0M | $300.0M | $360.0M | $443.0M | $353.0M | $399.0M | $444.0M |
| Net income | $351.0M | $318.0M | $215.0M | $336.0M | $434.0M | $305.0M | $339.0M | $362.0M |
| Diluted EPS | $1.23 | $1.11 | $0.75 | $1.18 | $1.52 | $1.07 | $1.20 | $1.28 |
| Free cash flow | $388.0M | $334.0M | $107.0M | $259.0M | $452.0M | $175.0M | $201.0M | $439.0M |

## Operating KPIs

| KPI | Latest | Period | Change on a year |
| --- | ---: | --- | --- |
| [Product revenue](https://aapwire.com/stocks/A/kpi/product-revenue) | $1.3B | quarter to 31 Jul 2026 | up 8.4% |
| [Non-Instrumentation and Other revenue](https://aapwire.com/stocks/A/kpi/non-instrumentation-and-other-revenue) | $1.2B | quarter to 31 Jul 2026 | up 8.4% |
| [Instrumentation revenue](https://aapwire.com/stocks/A/kpi/instrumentation-revenue) | $643.0M | quarter to 31 Jul 2026 | up 7.3% |
| [Services and Other revenue](https://aapwire.com/stocks/A/kpi/services-and-other-revenue) | $545.0M | quarter to 31 Jul 2026 | up 7.3% |
| [Agilent CrossLab revenue](https://aapwire.com/stocks/A/kpi/agilent-crosslab-revenue) | $786.0M | quarter to 31 Jul 2026 | up 5.6% |
| [Life Sciences and Diagnostics Markets revenue](https://aapwire.com/stocks/A/kpi/life-sciences-and-diagnostics-markets-revenue) | $746.0M | quarter to 31 Jul 2026 | up 11.3% |
| [Applied Markets revenue](https://aapwire.com/stocks/A/kpi/applied-markets-revenue) | $346.0M | quarter to 31 Jul 2026 | up 6.8% |
| [Rest Of World revenue](https://aapwire.com/stocks/A/kpi/rest-of-world-revenue) | $3.4B | fiscal year to 31 Oct 2025 | up 11.0% |
| [United States revenue](https://aapwire.com/stocks/A/kpi/united-states-revenue) | $2.3B | fiscal year to 31 Oct 2025 | up 4.3% |
| [China revenue](https://aapwire.com/stocks/A/kpi/china-revenue) | $1.2B | fiscal year to 31 Oct 2025 | up 0.6% |
| [Americas revenue](https://aapwire.com/stocks/A/kpi/americas-revenue) | $761.0M | quarter to 31 Jul 2026 | up 11.4% |
| [Asia Pacific revenue](https://aapwire.com/stocks/A/kpi/asia-pacific-revenue) | $613.0M | quarter to 31 Jul 2026 | up 8.9% |
| [Europe revenue](https://aapwire.com/stocks/A/kpi/europe-revenue) | $504.0M | quarter to 31 Jul 2026 | up 2.4% |

## Method

Each period is read from the report the company filed and checked against accounting identities; a figure that does not pass is left blank (—), never estimated. Free cash flow is operating cash flow less capital expenditure. Diluted EPS is as the company reported it, adjusted for later stock splits. Research information only, not investment advice.
